Axelpharm is suing Wyeth Holdings over a compulsory license for an anticancer drug
The Russian Axelpharm is demanding a compulsory license from the American Pfizer, probably for an antitumor drug based on bosutinib,...
The Russian Axelpharm is demanding a compulsory license from the American Pfizer, probably for an antitumor drug based on bosutinib,...
The Russian pharmaceutical distributor Axelpharm, having a patent for the crystalline form of osimertinib used in the treatment of lung...
German pharmaceutical manufacturer Bayer refused compensation of more than 400 million rubles. from Nativa (renamed Spectrum) for the use of...
A group of specialists from the Technical University of Denmark managed to obtain an effective chemotherapeutic drug against cancer, which...
The production of anticancer drugs and immunomodulators in the capital has increased 3.3 times since the beginning of the year....